Lord, Abbett & Co
GSK icon

Lord, Abbett & Co’s GSK GSK Stock Holding History

Lord, Abbett & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,538
Closed -$1.47M – 951
2015
Q1 		$1.47M Buy
25,538
+786
+3% +$45.1K ﹤0.01% 877
2014
Q4 		$1.32M Sell
24,752
-10,786
-30% -$603K ﹤0.01% 890
2014
Q3 		$2.04M Sell
35,538
-64,062
-64% -$3.93M 0.01% 892
2014
Q2 		$6.66M Sell
99,600
-58,979
-37% -$3.99M 0.02% 739
2014
Q1 		$10.6M Buy
+158,579
New +$10.7M 0.02% 616
2013
Q3 		– Sell
-432,080
Closed -$27M – 1050
2013
Q2 		$27M Buy
+432,080
New +$27.4M 0.06% 438

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lord, Abbett & Co's GSK Position: Q2 2015 in Review

Lord, Abbett & Co sold out of GSK (GSK) in Q2 2015, closing a stake of 25,538 shares — an estimated $1.47M sold.

Lord, Abbett & Co first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $27M in Q2 2013. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • Lord, Abbett & Co reported no remaining GSK position as of Q2 2015 after selling out during the quarter.
  • Lord, Abbett & Co sold 25,538 GSK shares in Q2 2015, an estimated $1.47M.
  • Lord, Abbett & Co first reported a position in GSK in Q2 2013 and held it in 6 quarters.
  • Lord, Abbett & Co's GSK position peaked at $27M in Q2 2013.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Lord, Abbett & Co's 13F filing for Q2 2015, filed 14 Aug 2015.